Fritextsökning
Innehållstyper
-
Why the world renown researcher Marc Tessier-Lavigne resigns as Stanford´s president
In mid-summer, neuroscientist Marc Tessier-Lavigne announced his resignation as President of Stanford following allegations of manipulated study data. According...
-
BioArctic moves forward with its candidate for Parkinson’s
BioArctic announces positive early phase study results for its drug candidate for Parkinson’s disease.
-
Thomas Eldered: ”Innovation is the key”
Thomas Eldered speaks in a web clip about the challenges facing the life science sector in the future and what he, as an investor, finds most interesting in new companies.
-
SupraCube - In life Science
Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...
-
Medical device quality assurance
Recordings from ZEISS Quality Innovation Days.
-
Precision and accuracy in liquid handling
How to evaluate and optimize liquid handling performance
-
The investor: “The major common diseases are hot again”
She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...
-
Bioscience – Groundbreaking Research & Diagnostics: Stockholm (2026)
-
From powder to implant
Quality assurance for additively manufactured implants.
-
Fundamental Aspects of Airy Disk Patterns
Knowledge Article from ZEISS.
-
Efter förseningen – nu har Ascelia lämnat in sin FDA-ansökan
Efter flera turer och en studie som fick göras om har nu Ascelia Pharma till slut lämnat in en ansökan om marknadsgodkännande i USA för kontrastmedlet Orviglance.
-
Trends and overview: ELRIG "Robotics and Automation"
Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic
-
Italian pharmaceutical company buys rights to immunotherapy from Sanofi
Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).
-
Anna Törner: Yes, I Am Sick, But Not Weak
”People often say that someone who is ill only has one wish—to get better. But I think that is not true. Someone who is ill also longs to be understood, to be r...
-
Thumbs down for lecanemab in the EU – “Very surprised”
The Azheimer's drug lecanemab has received a negative assessment from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), acc...
-
Healthcare study: Alzheimer’s blood test shows high accuracy
A blood test for identifying Alzheimer’s has now been tested in the general healthcare setting. According to the researchers, the test was 90% accurate in making a diagnosis.
-
SGS Fimko Ltd.
-
MSD discontinues two Keytruda trials
MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.
-
Prövning av pillervaccin mot covid-19 avbryts i USA
Det amerikanska hälsodepartementet har beordrat stopp för en statligt finansierad fas IIb-studie som skulle utvärdera ett potentiellt pillervaccin mot covid-19.
-
ZEISS Insights: Measurement of bone plates and screws
Get free access to technical paper.
-
A small thing that can solve your problems
If you are in need of a compact valve. Look no further! We have the VOVK
-
Festo liquid dispensing: going fast and slow
Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs
-
Gothenburg, the city of life science – We are ‘Little Boston’
Western Sweden is investing in life science within everything from advanced therapeutic drugs to femtech. At the same time, stakeholders are looking to other in...
-
Cytel Sweden